Arsenic trioxide in pediatric cancer – a case series and review of literature-Reference-Cited by-同舟云学术

Arsenic trioxide in pediatric cancer – a case series and review of literature

Published:2021-02-26 Issue:5 Volume:38 Page:471-485
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Abele Michael¹,Müller Sara-Lena²,Schleicher Sabine¹,Hartmann Ulrike³,Döring Michaela¹,Queudeville Manon¹,Lang Peter¹,Handgretinger Rupert¹,Ebinger Martin¹

Affiliation:

1. Pediatric Hematology/Oncology, Department of Pediatrics, University Hospital Tuebingen, Tuebingen, Germany

2. Clinic for Anaesthesiology, Critical Care, Emergency Medicine and Pain Management, Klinikum Ludwigsburg, Germany

3. Pharmacy, University Hospital Tuebingen, Tuebingen, Germany

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2021.1872748

Reference87 articles.

1. History of the Development of Arsenic Derivatives in Cancer Therapy

2. ARSENIC AS A THERAPEUTIC AGENT IN CHRONIC MYELOGENOUS LEUKEMIA

3. Arsenic trioxide — An old drug rediscovered

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maximizing arsenic trioxide's anticancer potential: Targeted nanocarriers for solid tumor therapy;Colloids and Surfaces B: Biointerfaces;2024-09

2. Arsenic trioxide: applications, mechanisms of action, toxicity and rescue strategies to date;Archives of Pharmacal Research;2023-12-26

3. Current approaches and strategies to identify Hedgehog signaling pathway inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2022-12

4. The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases;Pharmaceutics;2022-09-14

5. Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy;Pharmaceutics;2022-03-30